Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-24

Clinical Trial Update: Controlled, Randomized, Four-arm Comparative, Open Label, Multi-centric Clinical Trial to Compare the Efficacy and Safety Parameters of the Once-a-week or Once-a-month Administered 7000 IU, or 30000 IU Vitamin D (Cholecalciferol) to a 1000 IU Dosage Applied Daily in Vitamin D Deficient Patients [Phase 3]

View source ↗

Summary

A completed Phase 3 randomized trial comparing once-weekly 7000 IU or once-monthly 30000 IU vitamin D3 against daily 1000 IU in individuals with vitamin D defic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Semmelweis University | Conditions: Vitamin D Deficiency | Phase 3 | Status: COMPLETED